BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 37496243)

  • 21. Considerations for the use of proton-pump inhibitors in older adults.
    Desilets AR; Asal NJ; Dunican KC
    Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
    Singh A; Cresci GA; Kirby DF
    Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of the long-term use of proton pump inhibitors.
    Thomson AB; Sauve MD; Kassam N; Kamitakahara H
    World J Gastroenterol; 2010 May; 16(19):2323-30. PubMed ID: 20480516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitor therapy and potential long-term harm.
    Corleto VD; Festa S; Di Giulio E; Annibale B
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):3-8. PubMed ID: 24310148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risks of long-term use of proton pump inhibitors: a critical review.
    Jaynes M; Kumar AB
    Ther Adv Drug Saf; 2019; 10():2042098618809927. PubMed ID: 31019676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients' Knowledge and Pharmacists' Practice Regarding the Long-Term Side Effects of Proton Pump Inhibitors; a Cross-sectional Study.
    Alblooshi AJ; Baig MR; Anbar HS
    Arch Acad Emerg Med; 2024; 12(1):e35. PubMed ID: 38721447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011194. PubMed ID: 28271513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.
    Lam JR; Schneider JL; Zhao W; Corley DA
    JAMA; 2013 Dec; 310(22):2435-42. PubMed ID: 24327038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
    Targownik LE; Fisher DA; Saini SD
    Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton Pump Inhibitors: Review of Emerging Concerns.
    Nehra AK; Alexander JA; Loftus CG; Nehra V
    Mayo Clin Proc; 2018 Feb; 93(2):240-246. PubMed ID: 29406201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perils and pitfalls of long-term effects of proton pump inhibitors.
    Wilhelm SM; Rjater RG; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):443-51. PubMed ID: 23927671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
    Luk CP; Parsons R; Lee YP; Hughes JD
    Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton pump inhibitors for chronic obstructive pulmonary disease.
    Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications.
    Heidelbaugh JJ
    Ther Adv Drug Saf; 2013 Jun; 4(3):125-33. PubMed ID: 25083257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors, adverse events and increased risk of mortality.
    Lanas-Gimeno A; Hijos G; Lanas Á
    Expert Opin Drug Saf; 2019 Nov; 18(11):1043-1053. PubMed ID: 31498687
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
    Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
    J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013-2016.
    Daniels B; Pearson SA; Buckley NA; Bruno C; Zoega H
    Therap Adv Gastroenterol; 2020; 13():1756284820913743. PubMed ID: 32218806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease.
    Kamal F; Khan MA; Molnar MZ; Howden CW
    J Clin Gastroenterol; 2018 Jul; 52(6):468-476. PubMed ID: 29668562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.